Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ultrasonic Therapy | 14 | 2011 | 235 | 2.280 |
Why?
|
Magnetic Resonance Imaging | 105 | 2022 | 35326 | 1.680 |
Why?
|
Prostatic Neoplasms | 56 | 2021 | 10999 | 1.630 |
Why?
|
Leiomyoma | 11 | 2007 | 727 | 1.350 |
Why?
|
Brachytherapy | 25 | 2013 | 1247 | 1.200 |
Why?
|
Prostate | 21 | 2022 | 1743 | 1.170 |
Why?
|
Uterine Neoplasms | 13 | 2007 | 1511 | 1.090 |
Why?
|
Image Interpretation, Computer-Assisted | 13 | 2019 | 3344 | 0.780 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2015 | 181 | 0.740 |
Why?
|
Image Enhancement | 15 | 2016 | 2928 | 0.570 |
Why?
|
Pattern Recognition, Automated | 5 | 2016 | 1000 | 0.570 |
Why?
|
Biopsy, Needle | 9 | 2007 | 1637 | 0.530 |
Why?
|
Imaging, Three-Dimensional | 10 | 2013 | 4035 | 0.510 |
Why?
|
Subtraction Technique | 5 | 2004 | 527 | 0.510 |
Why?
|
Radiology | 3 | 2020 | 2080 | 0.510 |
Why?
|
Radiology, Interventional | 2 | 2015 | 460 | 0.450 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2009 | 3757 | 0.450 |
Why?
|
Neurosurgery | 2 | 2016 | 643 | 0.390 |
Why?
|
Monitoring, Intraoperative | 4 | 2005 | 954 | 0.370 |
Why?
|
Prostatectomy | 10 | 2009 | 1858 | 0.360 |
Why?
|
Algorithms | 12 | 2016 | 13872 | 0.340 |
Why?
|
Prenatal Diagnosis | 5 | 2004 | 1227 | 0.340 |
Why?
|
Vaginal Neoplasms | 2 | 2006 | 106 | 0.320 |
Why?
|
Light Coagulation | 1 | 2007 | 72 | 0.310 |
Why?
|
Prostate-Specific Antigen | 12 | 2007 | 2441 | 0.290 |
Why?
|
Uterine Diseases | 3 | 1997 | 135 | 0.290 |
Why?
|
Ureteral Calculi | 3 | 2003 | 108 | 0.280 |
Why?
|
Ultrasonography, Interventional | 3 | 2011 | 1480 | 0.270 |
Why?
|
Bile Duct Diseases | 1 | 2006 | 99 | 0.260 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2006 | 100 | 0.260 |
Why?
|
Prostatic Hyperplasia | 5 | 2000 | 522 | 0.260 |
Why?
|
Body Water | 1 | 2006 | 342 | 0.250 |
Why?
|
Sensitivity and Specificity | 26 | 2016 | 14740 | 0.250 |
Why?
|
Urinary Bladder | 5 | 2006 | 1153 | 0.230 |
Why?
|
Urinary Retention | 2 | 2005 | 110 | 0.230 |
Why?
|
Expert Systems | 1 | 2003 | 81 | 0.230 |
Why?
|
Pancreatic Diseases | 1 | 2006 | 350 | 0.230 |
Why?
|
Surgery, Computer-Assisted | 4 | 2007 | 1008 | 0.230 |
Why?
|
Menstrual Cycle | 1 | 2006 | 550 | 0.220 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2019 | 2732 | 0.220 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2003 | 141 | 0.220 |
Why?
|
Male | 91 | 2023 | 349022 | 0.210 |
Why?
|
Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2001 | 7 | 0.210 |
Why?
|
Diagnostic Imaging | 5 | 2007 | 3497 | 0.210 |
Why?
|
Humans | 134 | 2023 | 739398 | 0.210 |
Why?
|
ROC Curve | 11 | 2003 | 3526 | 0.210 |
Why?
|
Congenital Abnormalities | 2 | 2004 | 708 | 0.210 |
Why?
|
Software Validation | 1 | 2001 | 58 | 0.200 |
Why?
|
Reproducibility of Results | 18 | 2022 | 19811 | 0.200 |
Why?
|
Computer Systems | 4 | 2006 | 484 | 0.200 |
Why?
|
Image Processing, Computer-Assisted | 11 | 2022 | 8977 | 0.200 |
Why?
|
Cholangitis, Sclerosing | 1 | 2023 | 157 | 0.200 |
Why?
|
Genital Neoplasms, Female | 3 | 2016 | 513 | 0.190 |
Why?
|
Models, Statistical | 6 | 2016 | 5113 | 0.180 |
Why?
|
History, 21st Century | 2 | 2016 | 1534 | 0.180 |
Why?
|
Diseases in Twins | 1 | 2001 | 449 | 0.180 |
Why?
|
Neoplasm Staging | 19 | 2007 | 10961 | 0.170 |
Why?
|
Contrast Media | 11 | 2007 | 5293 | 0.160 |
Why?
|
Pentetic Acid | 2 | 1995 | 213 | 0.160 |
Why?
|
Artifacts | 5 | 2012 | 1905 | 0.160 |
Why?
|
History, 20th Century | 2 | 2016 | 2742 | 0.160 |
Why?
|
Ovarian Neoplasms | 4 | 2003 | 4815 | 0.150 |
Why?
|
Magnetic Resonance Angiography | 2 | 2001 | 1441 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2013 | 9122 | 0.150 |
Why?
|
Placental Insufficiency | 1 | 2017 | 51 | 0.150 |
Why?
|
Computer Simulation | 9 | 2016 | 6237 | 0.150 |
Why?
|
Oxides | 4 | 2003 | 404 | 0.140 |
Why?
|
Phantoms, Imaging | 5 | 2022 | 2504 | 0.140 |
Why?
|
Endometrial Neoplasms | 1 | 2006 | 1351 | 0.140 |
Why?
|
Hungary | 1 | 2016 | 84 | 0.140 |
Why?
|
Ultrasonography, Prenatal | 1 | 2004 | 1689 | 0.140 |
Why?
|
Statistics as Topic | 1 | 2003 | 2373 | 0.140 |
Why?
|
Abortion, Therapeutic | 1 | 1995 | 35 | 0.140 |
Why?
|
Biopsy | 6 | 2013 | 6722 | 0.140 |
Why?
|
Placenta, Retained | 1 | 1995 | 22 | 0.130 |
Why?
|
Urinary Reservoirs, Continent | 1 | 1995 | 29 | 0.130 |
Why?
|
Renal Veins | 2 | 1992 | 108 | 0.130 |
Why?
|
Rectum | 5 | 2006 | 900 | 0.130 |
Why?
|
Oxygen | 2 | 2017 | 4158 | 0.130 |
Why?
|
Organometallic Compounds | 2 | 1995 | 667 | 0.120 |
Why?
|
Regression Analysis | 2 | 2001 | 6452 | 0.120 |
Why?
|
Iodine Radioisotopes | 5 | 2000 | 1031 | 0.120 |
Why?
|
Middle Aged | 52 | 2023 | 212863 | 0.120 |
Why?
|
Robotics | 3 | 2007 | 890 | 0.120 |
Why?
|
Predictive Value of Tests | 8 | 2020 | 15036 | 0.120 |
Why?
|
Androgen Antagonists | 2 | 2003 | 1343 | 0.120 |
Why?
|
Radiotherapy Dosage | 6 | 2013 | 2872 | 0.120 |
Why?
|
Fetus | 1 | 2001 | 1877 | 0.110 |
Why?
|
Abdominal Neoplasms | 3 | 2003 | 289 | 0.110 |
Why?
|
Aged | 41 | 2019 | 162698 | 0.110 |
Why?
|
Uterus | 2 | 1997 | 712 | 0.110 |
Why?
|
Bayes Theorem | 1 | 2001 | 2303 | 0.110 |
Why?
|
Azasteroids | 1 | 1993 | 37 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 18 | 2006 | 20055 | 0.110 |
Why?
|
Feasibility Studies | 4 | 2006 | 5058 | 0.110 |
Why?
|
Pelvic Neoplasms | 3 | 2003 | 254 | 0.110 |
Why?
|
Female | 54 | 2023 | 378853 | 0.110 |
Why?
|
Research | 1 | 2001 | 2001 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2001 | 1232 | 0.100 |
Why?
|
Placenta Accreta | 1 | 1995 | 225 | 0.100 |
Why?
|
Androstenes | 1 | 1993 | 168 | 0.100 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 1993 | 106 | 0.100 |
Why?
|
Panniculitis, Peritoneal | 1 | 1991 | 11 | 0.100 |
Why?
|
Smoking Cessation | 1 | 2023 | 2067 | 0.100 |
Why?
|
Principal Component Analysis | 2 | 2004 | 937 | 0.100 |
Why?
|
Patient Selection | 5 | 2006 | 4211 | 0.090 |
Why?
|
Mesentery | 1 | 1991 | 205 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2003 | 2124 | 0.090 |
Why?
|
Iron | 4 | 2003 | 1776 | 0.090 |
Why?
|
Adult | 40 | 2023 | 213394 | 0.090 |
Why?
|
Pelvis | 2 | 2004 | 718 | 0.090 |
Why?
|
Treatment Outcome | 16 | 2013 | 62693 | 0.090 |
Why?
|
Brain Mapping | 1 | 2004 | 6666 | 0.080 |
Why?
|
Adenocarcinoma | 8 | 2005 | 6318 | 0.080 |
Why?
|
Magnetics | 1 | 2012 | 609 | 0.080 |
Why?
|
Elasticity Imaging Techniques | 1 | 2013 | 385 | 0.080 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1995 | 778 | 0.080 |
Why?
|
Models, Biological | 4 | 2006 | 9609 | 0.080 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2006 | 1625 | 0.080 |
Why?
|
Gadolinium DTPA | 4 | 2004 | 836 | 0.070 |
Why?
|
Prospective Studies | 15 | 2013 | 53037 | 0.070 |
Why?
|
Leiomyomatosis | 1 | 2007 | 70 | 0.070 |
Why?
|
Phlebography | 2 | 2001 | 333 | 0.070 |
Why?
|
Infertility, Female | 2 | 2007 | 784 | 0.070 |
Why?
|
Radiation Injuries | 3 | 2003 | 1161 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 2 | 1998 | 2196 | 0.070 |
Why?
|
Lymphatic Metastasis | 4 | 2003 | 2897 | 0.070 |
Why?
|
Postoperative Care | 2 | 2007 | 1477 | 0.070 |
Why?
|
Colon, Sigmoid | 1 | 2006 | 118 | 0.070 |
Why?
|
Seminal Vesicles | 2 | 2004 | 100 | 0.070 |
Why?
|
Radiography | 3 | 2013 | 6998 | 0.070 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 380 | 0.070 |
Why?
|
Intestinal Polyps | 1 | 1985 | 100 | 0.070 |
Why?
|
Normal Distribution | 2 | 2016 | 282 | 0.070 |
Why?
|
Premenopause | 2 | 2006 | 1028 | 0.060 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2007 | 812 | 0.060 |
Why?
|
Intraoperative Care | 3 | 2004 | 766 | 0.060 |
Why?
|
Therapy, Computer-Assisted | 1 | 2007 | 274 | 0.060 |
Why?
|
Ultrasonography | 8 | 2017 | 5941 | 0.060 |
Why?
|
Pregnancy | 9 | 2017 | 29002 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2013 | 38942 | 0.060 |
Why?
|
Thrombosis | 3 | 1995 | 2961 | 0.060 |
Why?
|
Radiometry | 2 | 2000 | 801 | 0.060 |
Why?
|
Needles | 1 | 2007 | 448 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2007 | 76631 | 0.060 |
Why?
|
Carcinoma | 2 | 2007 | 2361 | 0.060 |
Why?
|
Equipment Design | 2 | 2003 | 3583 | 0.060 |
Why?
|
Lactates | 1 | 2004 | 434 | 0.060 |
Why?
|
Urethra | 2 | 2003 | 401 | 0.060 |
Why?
|
Observer Variation | 3 | 2000 | 2589 | 0.060 |
Why?
|
Pregnancy Trimester, Second | 2 | 2004 | 732 | 0.060 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2007 | 335 | 0.060 |
Why?
|
Boston | 1 | 2016 | 9314 | 0.060 |
Why?
|
Body Temperature | 1 | 2006 | 775 | 0.060 |
Why?
|
Metabolism, Inborn Errors | 1 | 2004 | 288 | 0.050 |
Why?
|
Self Medication | 1 | 2002 | 117 | 0.050 |
Why?
|
Vagina | 2 | 2006 | 822 | 0.050 |
Why?
|
Taxoids | 1 | 2005 | 661 | 0.050 |
Why?
|
Niacin | 1 | 2002 | 116 | 0.050 |
Why?
|
Pregnancy Trimester, Third | 1 | 2004 | 568 | 0.050 |
Why?
|
Body Temperature Regulation | 1 | 2003 | 252 | 0.050 |
Why?
|
Liver Neoplasms | 6 | 2000 | 4216 | 0.050 |
Why?
|
Vascular Diseases | 1 | 1990 | 1152 | 0.050 |
Why?
|
Ovary | 3 | 2001 | 982 | 0.050 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2005 | 623 | 0.050 |
Why?
|
Ultrasonography, Doppler | 2 | 2000 | 460 | 0.050 |
Why?
|
Calibration | 2 | 2000 | 818 | 0.050 |
Why?
|
Biophysical Phenomena | 1 | 2001 | 331 | 0.050 |
Why?
|
Salvage Therapy | 1 | 2007 | 1269 | 0.050 |
Why?
|
Twins, Conjoined | 1 | 2000 | 41 | 0.050 |
Why?
|
Preoperative Care | 3 | 2009 | 2238 | 0.050 |
Why?
|
Biophysics | 1 | 2001 | 384 | 0.050 |
Why?
|
Equipment Safety | 1 | 2001 | 264 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2016 | 2716 | 0.050 |
Why?
|
Acidosis, Lactic | 1 | 2001 | 141 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2006 | 7897 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2007 | 966 | 0.040 |
Why?
|
Pilot Projects | 2 | 2006 | 8275 | 0.040 |
Why?
|
Leiomyosarcoma | 1 | 2003 | 469 | 0.040 |
Why?
|
Fetofetal Transfusion | 1 | 2000 | 104 | 0.040 |
Why?
|
Cerebral Ventricles | 1 | 2001 | 544 | 0.040 |
Why?
|
Urination Disorders | 1 | 2000 | 240 | 0.040 |
Why?
|
Fetal Heart | 1 | 2000 | 276 | 0.040 |
Why?
|
Brain Neoplasms | 3 | 2004 | 8791 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2001 | 536 | 0.040 |
Why?
|
Diagnosis, Differential | 7 | 2004 | 12948 | 0.040 |
Why?
|
Neoplasms | 2 | 2023 | 21507 | 0.040 |
Why?
|
Brazil | 1 | 2022 | 1264 | 0.040 |
Why?
|
Urogenital System | 1 | 1998 | 85 | 0.040 |
Why?
|
Drug Interactions | 1 | 2002 | 1456 | 0.040 |
Why?
|
Female Urogenital Diseases | 1 | 1998 | 52 | 0.040 |
Why?
|
Brain | 3 | 2017 | 26345 | 0.040 |
Why?
|
Hysterosalpingography | 1 | 1997 | 30 | 0.040 |
Why?
|
Quality of Life | 4 | 2023 | 12640 | 0.040 |
Why?
|
Ferrosoferric Oxide | 4 | 2003 | 364 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2013 | 57650 | 0.040 |
Why?
|
Liver | 5 | 2017 | 7449 | 0.040 |
Why?
|
Reference Values | 1 | 2004 | 4983 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2001 | 1850 | 0.040 |
Why?
|
Patient Care Planning | 1 | 2002 | 918 | 0.040 |
Why?
|
Magnetite Nanoparticles | 4 | 2003 | 324 | 0.040 |
Why?
|
Dextrans | 4 | 2003 | 590 | 0.040 |
Why?
|
Lactic Acid | 1 | 2001 | 1132 | 0.040 |
Why?
|
Neoplasm Invasiveness | 3 | 2004 | 3603 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2003 | 2711 | 0.030 |
Why?
|
Leg | 1 | 2001 | 1107 | 0.030 |
Why?
|
Fallopian Tubes | 1 | 1997 | 182 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2001 | 903 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2001 | 1279 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2024 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2003 | 1127 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2004 | 6370 | 0.030 |
Why?
|
Priapism | 1 | 1995 | 30 | 0.030 |
Why?
|
Angiomyolipoma | 1 | 1996 | 185 | 0.030 |
Why?
|
Hyperoxia | 1 | 2017 | 264 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2003 | 1497 | 0.030 |
Why?
|
Penile Erection | 1 | 1995 | 97 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2007 | 3382 | 0.030 |
Why?
|
Urologic Diseases | 1 | 1997 | 239 | 0.030 |
Why?
|
Perfusion | 1 | 2019 | 1354 | 0.030 |
Why?
|
Pregnancy, Ectopic | 1 | 1995 | 140 | 0.030 |
Why?
|
Lymphatic Diseases | 1 | 1995 | 324 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 1985 | 2530 | 0.030 |
Why?
|
Forecasting | 2 | 2001 | 2952 | 0.030 |
Why?
|
Neoplasms, Second Primary | 1 | 2001 | 1045 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2000 | 1423 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1838 | 0.030 |
Why?
|
Vena Cava, Inferior | 1 | 1995 | 432 | 0.030 |
Why?
|
Organ Size | 1 | 2017 | 2247 | 0.030 |
Why?
|
Finasteride | 1 | 1993 | 89 | 0.030 |
Why?
|
Health Behavior | 1 | 2023 | 2624 | 0.030 |
Why?
|
Cystadenoma | 1 | 1991 | 84 | 0.030 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1997 | 717 | 0.030 |
Why?
|
Genitalia, Female | 1 | 1992 | 146 | 0.020 |
Why?
|
Cryotherapy | 2 | 2003 | 154 | 0.020 |
Why?
|
Spleen | 2 | 1994 | 2359 | 0.020 |
Why?
|
Palpation | 1 | 1991 | 166 | 0.020 |
Why?
|
Genital Diseases, Female | 1 | 1992 | 195 | 0.020 |
Why?
|
Sclerosis | 1 | 1991 | 210 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2003 | 3799 | 0.020 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 1990 | 41 | 0.020 |
Why?
|
Gadolinium | 1 | 1995 | 951 | 0.020 |
Why?
|
Lung Diseases, Fungal | 1 | 1991 | 122 | 0.020 |
Why?
|
Thoracic Diseases | 1 | 1991 | 96 | 0.020 |
Why?
|
Cystectomy | 1 | 1995 | 675 | 0.020 |
Why?
|
Biliary Tract Neoplasms | 1 | 1991 | 177 | 0.020 |
Why?
|
Vascular Patency | 1 | 1992 | 888 | 0.020 |
Why?
|
Granulomatous Disease, Chronic | 1 | 1991 | 173 | 0.020 |
Why?
|
Proteinuria | 1 | 1992 | 654 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2007 | 15511 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1998 | 3453 | 0.020 |
Why?
|
Embolism | 1 | 1992 | 408 | 0.020 |
Why?
|
Sialography | 1 | 1988 | 4 | 0.020 |
Why?
|
Aspergillosis | 1 | 1991 | 235 | 0.020 |
Why?
|
Parotid Diseases | 1 | 1988 | 46 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1539 | 0.020 |
Why?
|
Computational Biology | 1 | 2001 | 3506 | 0.020 |
Why?
|
Motion | 1 | 2012 | 803 | 0.020 |
Why?
|
Erectile Dysfunction | 1 | 1991 | 458 | 0.020 |
Why?
|
Male Urogenital Diseases | 1 | 2007 | 48 | 0.020 |
Why?
|
Abdomen | 1 | 1993 | 1104 | 0.020 |
Why?
|
Probability | 1 | 1992 | 2500 | 0.020 |
Why?
|
Kidney Neoplasms | 2 | 1996 | 4189 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 1995 | 1015 | 0.020 |
Why?
|
Learning | 1 | 1996 | 1695 | 0.020 |
Why?
|
Aortic Aneurysm | 1 | 1991 | 643 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2004 | 25470 | 0.020 |
Why?
|
Pain | 2 | 2003 | 4923 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 8960 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2006 | 125 | 0.020 |
Why?
|
Software | 1 | 2000 | 4423 | 0.020 |
Why?
|
Neuronavigation | 1 | 2007 | 167 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2001 | 5721 | 0.020 |
Why?
|
Utah | 1 | 2004 | 125 | 0.020 |
Why?
|
Laser Therapy | 2 | 2003 | 1065 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2003 | 1771 | 0.020 |
Why?
|
Postoperative Period | 1 | 1990 | 1835 | 0.020 |
Why?
|
Perimenopause | 1 | 2006 | 139 | 0.020 |
Why?
|
Time Factors | 4 | 2007 | 40050 | 0.020 |
Why?
|
Retroperitoneal Neoplasms | 1 | 1988 | 334 | 0.020 |
Why?
|
Lymphoma | 1 | 1993 | 1873 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 1992 | 1383 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2006 | 431 | 0.010 |
Why?
|
Life Tables | 1 | 2003 | 370 | 0.010 |
Why?
|
Neoadjuvant Therapy | 2 | 2005 | 2688 | 0.010 |
Why?
|
Receptors, LHRH | 1 | 2003 | 159 | 0.010 |
Why?
|
Precipitating Factors | 1 | 2002 | 53 | 0.010 |
Why?
|
Proctitis | 1 | 2002 | 40 | 0.010 |
Why?
|
Elasticity | 1 | 2004 | 656 | 0.010 |
Why?
|
Ejaculation | 1 | 2002 | 58 | 0.010 |
Why?
|
Prothrombin Time | 1 | 2002 | 116 | 0.010 |
Why?
|
Breast | 1 | 1992 | 1950 | 0.010 |
Why?
|
Fetal Death | 1 | 2004 | 446 | 0.010 |
Why?
|
Myocardium | 1 | 1995 | 4788 | 0.010 |
Why?
|
Decision Making | 1 | 1996 | 3854 | 0.010 |
Why?
|
Fertility | 1 | 2007 | 775 | 0.010 |
Why?
|
Mammaplasty | 1 | 1992 | 1185 | 0.010 |
Why?
|
Retroperitoneal Space | 2 | 1995 | 171 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1995 | 1676 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1995 | 2867 | 0.010 |
Why?
|
Radiation Dosage | 2 | 2000 | 1920 | 0.010 |
Why?
|
Radiotherapy, Conformal | 1 | 2004 | 548 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2004 | 570 | 0.010 |
Why?
|
Immobilization | 1 | 2001 | 236 | 0.010 |
Why?
|
Clinical Competence | 1 | 1996 | 4671 | 0.010 |
Why?
|
Chronic Disease | 2 | 1992 | 9133 | 0.010 |
Why?
|
Adolescent | 8 | 2003 | 85405 | 0.010 |
Why?
|
Quality Control | 1 | 2003 | 842 | 0.010 |
Why?
|
Posture | 1 | 2004 | 966 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1998 | 5213 | 0.010 |
Why?
|
Risk Assessment | 3 | 2007 | 23294 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8669 | 0.010 |
Why?
|
Lymph Nodes | 2 | 2003 | 3454 | 0.010 |
Why?
|
Hemorrhage | 1 | 1991 | 3441 | 0.010 |
Why?
|
Radiotherapy, Computer-Assisted | 1 | 2000 | 94 | 0.010 |
Why?
|
Peritoneum | 1 | 2000 | 226 | 0.010 |
Why?
|
Acute Disease | 2 | 2005 | 7128 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2007 | 1162 | 0.010 |
Why?
|
False Positive Reactions | 2 | 1992 | 982 | 0.010 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2000 | 364 | 0.010 |
Why?
|
Analgesia | 1 | 2003 | 458 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2003 | 1583 | 0.010 |
Why?
|
Safety | 1 | 2003 | 1186 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12761 | 0.010 |
Why?
|
Perineum | 1 | 2000 | 211 | 0.010 |
Why?
|
Biomedical Engineering | 1 | 2000 | 295 | 0.010 |
Why?
|
Drainage | 1 | 2003 | 1139 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1988 | 1373 | 0.010 |
Why?
|
Androgens | 1 | 2005 | 1270 | 0.010 |
Why?
|
United States | 2 | 2009 | 69573 | 0.010 |
Why?
|
Movement | 1 | 2004 | 1481 | 0.010 |
Why?
|
Antibiotic Prophylaxis | 1 | 2002 | 631 | 0.010 |
Why?
|
Hysterectomy | 1 | 2003 | 926 | 0.010 |
Why?
|
Case-Control Studies | 1 | 1995 | 21694 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2003 | 1099 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4935 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6516 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1996 | 6726 | 0.010 |
Why?
|
Heart | 2 | 2003 | 4466 | 0.010 |
Why?
|
Hyperthermia, Induced | 1 | 2000 | 400 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2004 | 12237 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15153 | 0.010 |
Why?
|
Hematuria | 1 | 1997 | 234 | 0.010 |
Why?
|
Gestational Age | 1 | 2004 | 3486 | 0.010 |
Why?
|
Linear Models | 1 | 2006 | 5948 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 1990 | 3101 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 2003 | 1471 | 0.010 |
Why?
|
Collateral Circulation | 1 | 1995 | 287 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23355 | 0.010 |
Why?
|
Penis | 1 | 1995 | 207 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1993 | 186 | 0.010 |
Why?
|
Hepatic Veins | 1 | 1993 | 112 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2277 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2003 | 6871 | 0.010 |
Why?
|
Cryosurgery | 1 | 1998 | 451 | 0.010 |
Why?
|
Abdominal Muscles | 1 | 1993 | 162 | 0.010 |
Why?
|
Dogs | 1 | 1998 | 3915 | 0.010 |
Why?
|
Bile Ducts | 1 | 1993 | 281 | 0.010 |
Why?
|
Specialization | 1 | 1997 | 776 | 0.010 |
Why?
|
Portal Vein | 1 | 1993 | 433 | 0.010 |
Why?
|
Child | 3 | 1995 | 77033 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 1995 | 884 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2270 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2003 | 2737 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 13002 | 0.010 |
Why?
|
Hypertrophy | 1 | 1992 | 565 | 0.010 |
Why?
|
Melanoma | 1 | 1988 | 5446 | 0.010 |
Why?
|
Equipment Failure | 1 | 1992 | 580 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2003 | 12328 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1995 | 3510 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1991 | 504 | 0.010 |
Why?
|
Research Design | 1 | 2004 | 5959 | 0.010 |
Why?
|
Polysomnography | 1 | 1995 | 1765 | 0.010 |
Why?
|
Medicine | 1 | 1997 | 930 | 0.010 |
Why?
|
Colon | 1 | 1996 | 1771 | 0.000 |
Why?
|
Endoscopy | 1 | 1998 | 1762 | 0.000 |
Why?
|
Pancreas | 1 | 1993 | 1678 | 0.000 |
Why?
|
Angiography | 1 | 1991 | 1634 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1995 | 2789 | 0.000 |
Why?
|
Heart Defects, Congenital | 1 | 2000 | 4546 | 0.000 |
Why?
|
Aorta | 1 | 1991 | 2048 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2006 | 15194 | 0.000 |
Why?
|
Logistic Models | 1 | 1997 | 13402 | 0.000 |
Why?
|
Electrocardiography | 1 | 1995 | 6426 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1993 | 3280 | 0.000 |
Why?
|
Child, Preschool | 2 | 1995 | 40802 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 71974 | 0.000 |
Why?
|
Age Factors | 1 | 1997 | 18349 | 0.000 |
Why?
|
Prognosis | 1 | 1996 | 28901 | 0.000 |
Why?
|
Infant | 1 | 1995 | 34923 | 0.000 |
Why?
|
Animals | 1 | 1998 | 168368 | 0.000 |
Why?
|